Dr. Raymond K.F. Ch’ien is Chairman of Hang Seng Bank Limited. Dr. Ch’ien also serves on the boards of Hongkong and Shanghai Banking Corporation Limited, China Resources Power Holdings Company Limited and Swiss Re Limited. Dr. Ch’ien was Chairman of MTR Corporation Limited from July 2003 to December 2015 and Chairman of CDC Corporation from January 1999 to October 2011 and its subsidiary, China.com Inc. from November 1999 to March 2013.
In public service, Dr. Ch’ien is a member of the Economic Development Commission of the Hong Kong SAR Government. He is a member of the Standing Committee of the Tianjin Municipal Committee of the Chinese People’s Political Consultative Conference and is an honorary President and past Chairman of the Federation of Hong Kong Industries. From 1992 to 1997, Dr. Ch’ien was a member of the Executive Council of Hong Kong, then under British Administration. He was appointed a member of the Executive Council of the Hong Kong SAR on July 1, 1997 and served until June 2002. Dr. Ch’ien was Chairman of the Hong Kong/European Union Business Cooperation Committee from 2005 to January 2012. He was a Hong Kong member of the APEC Business Advisory Council from 2004 to 2009. Dr. Ch’ien was previously Chairman of the Advisory Committee on Corruption of the Independent Commission Against Corruption; The Hong Kong/Japan Business Cooperation Committee; the Industry and Technology Development Council and the Hong Kong Industrial Technology Centre Corporation Limited.
Dr. Ch’ien received a doctoral degree in Economics from the University of Pennsylvania in 1978 and was a Trustee of the University from 2006 to 2016. Dr. Ch’ien was appointed a Justice of the Peace in 1993 and a Commander in the Most Excellent Order of the British Empire in 1994. In 1999, he was awarded the Gold Bauhinia Star medal. In August 2008, Dr. Ch’ien was conferred the honour of Chevalier de l’Ordre du Mérite Agricole of France.
Dr. Lee is a 35-year pioneer of the high-tech industry, spending the first half of his career managing large organizations in Fortune 100 companies, and the second half as a serial entrepreneur. During this time, he conducted business globally, and in the last 15 years, he was heavily involved with running businesses in China. Since 2010, he is also Adjunct Professor and Professor of Practice (Entrepreneurship) at The Chinese University of Hong Kong Business School where he also serves as the Associate Director of the MBA Program, the Associate Director of the CUHK Center for Entrepreneurship and the Executive Director of the Center for Business Innovation & Globalization (Shenzhen and Hong Kong). Until late 2012 (when the company was acquired), he was Executive Chairman of Achievo Corporation (one of the largest China IT services companies). He co-founded Achievo in early 2002 and served as its Chairman and CEO until December 2008, when the company reached over 2500 people in size, more than 2000 of whom were in China. From 2002 to 2007, he was also CEO of Accela, Inc. (board member from 1999-2013) and led that company to become a dominant government enterprise software firm in the US. Until November 2001, he was president & CEO of Inxight Software, a Xerox-PARC spinout that tripled in revenues and raised venture funding under his leadership (now part of SAP). Before Inxight, he was chairman, CEO and president of Insignia Solutions, a software company he took public on NASDAQ in 1995. Previously, he was executive vice president of Symantec (NASDAQ: SYMC - software), where among many achievements including rapid growth, he acquired and integrated 6 companies, including Norton Computing which became a legendary M&A success story in the Silicon Valley. Dr. Lee was senior vice president of Shared Medical Systems (since acquired by Siemens) and was at IBM (responsible for its office systems software, healthcare industry software, overall software engineering and various systems/communications software) and Computer Sciences Corporation for many years. Dr. Lee is currently on the board of Osel, Inc., a biopharmaceutical startup, and was previously on the boards of S3, Inc. (NASDAQ: SIII - semiconductor) and SONICblue (NASDAQ: SBLU - digital media devices). He also serves as advisor to various Western and Chinese companies and investment funds, besides being a venture partner, limited partner and angel investor himself.
Dr. Lee participates in high-tech developments all over the world. During Mr. CH Tung's first official visit to the Silicon Valley as Hong Kong Chief Executive in June 1999, Dr. Lee was the co-host and speaker at a luncheon in Mr. Tung's honor. At Insignia Solutions, Dr. Lee hosted a luncheon for HM Queen Elizabeth II who paid an extended visit to his company's offices in the UK after the company won multiple Queen's Awards. In 1996, Dr. Lee was invited to the Philippines to meet President Ramos and other top leaders to help formulate a high-tech initiative for that country. His business and professional activities in China have put him in frequent contact with senior government officials there. Dr. Lee has met with many heads-of-state and senior government officials during their visits to the Silicon Valley, particularly those from Asia/China.
As a result of his active professional and community activities, including serving as the Global Chairman of the Board of Trustee of the AAMA (Asia America MultiTechnology Association), Chairman of the AAMA Pearl River Delta Chapter, former vice chairman of HYSTA’s China Global Services Alliance, former board member of Monte Jade Science and Technology Association (West Coast) and Asia Society President’s Circle, Dr. Lee is well known to the Silicon Valley and Asian media. He was featured in several books on Chinese-American successful entrepreneurs, and appeared frequently in print, web, radio and TV media globally. Dr. Lee is an accomplished public speaker.
Dr. Lee grew up in Hong Kong. He holds Ph.D. and MS degrees from UCLA, and a BA from UC Berkeley, all in computer science. He resides in the Silicon Valley. Dr. Lee is fluent in English and Chinese (Cantonese and Mandarin).
Mr Yang Xiangyang, Chairman of Shenzhen Resources Investment & Development Co., Ltd., President of Shenzhen Yuanxing Biopharmaceutical Co., Ltd., and professional angel investor, as Advisory Board Member of its research center, Center for Business Innovation and Globalization (Center BiG) with immediate effect. Mr Yang will contribute his extensive experience and expertise in enterprise investment to promote entrepreneurial spirit in Shenzhen and Hong Kong.